| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |